Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
carg tt score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–5
  • Intermediate Risk6–9
  • High Risk10–23
Direct Clinical Answer

The Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include sex. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

The CARG-TT estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients (age >65). It uses 11 geriatric assessment variables, laboratory values, and patient characteristics to predict chemotherapy toxicity risk.

Clinical Indication

The Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT) is indicated for bedside clinical practice to support The CARG-TT estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients (age >65). It uses 11 geriatric assessment variables, laboratory values, and patient characteristics to predict chemotherapy toxicity risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Recommended by ASCO guidelines for geriatric oncology assessment.

Formula & Variables:

Score = (2 × age_72_or_older) + (2 × gi_gu_cancer) + (2 × standard_dose_chemo) + (2 × polychemotherapy) + (3 × hemoglobin_low) + (3 × creatinine_clearance_low) + (2 × hearing_impaired) + (3 × falls_past_6_months) + (1 × medication_assistance) + (2 × walking_limited) + (1 × social_activity_decreased)

Input Parameters

NameTypeRequiredDescription
sexstringYesPatient sex (used for hemoglobin thresholds)
age_72_or_olderstringYesPatient age 72 years or older
gi_gu_cancerstringYesGastrointestinal or genitourinary cancer type
standard_dose_chemostringYesStandard-dose chemotherapy (vs. reduced dose)
polychemotherapystringYesPolychemotherapy (more than one chemotherapy drug)
hemoglobin_lowstringYesLow hemoglobin (males <11 g/dL, females <10 g/dL)
creatinine_clearance_lowstringYesCreatinine clearance <34 mL/min
hearing_impairedstringYesHearing fair, poor, or totally deaf (vs. excellent/good)
falls_past_6_monthsstringYesHistory of falls in the preceding 6 months
medication_assistancestringYesNeeds assistance with medication use
walking_limitedstringYesLimited in walking one block or more
social_activity_decreasedstringYesDecreased social activity because of health

Score Interpretation & Guidance

RangeStageDescription
0–5Low Risk30% risk of grade ≥3 toxicity
6–9Intermediate Risk52% risk of grade ≥3 toxicity
10–23High Risk83% risk of grade ≥3 toxicity

Evidence-Based References (EBM)

  • Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011 Sep 1;29(25):3457-65. doi: 10.1200/JCO.2011.34.7625.DOI: 10.1200/JCO.2011.34.7625
  • Magnuson A, Sattar S, Nightingale G, Saracino R, Skoneczka J, Trevino KM, et al. A practical guide to geriatric syndromes in older adults with cancer: A focus on falls, cognition, polypharmacy, and depression. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e96-e109. doi: 10.1200/EDBK_237641.DOI: 10.1200/EDBK_237641
  • Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul 1;118(13):3377-86. doi: 10.1002/cncr.26646.DOI: 10.1002/cncr.26646

Related calculators